CS-3150
Phase 3Completed 1 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Hypertension With Moderate Renal Impairment
Conditions
Hypertension With Moderate Renal Impairment
Trial Timeline
Jun 1, 2016 → May 15, 2017
NCT ID
NCT02807987About CS-3150
CS-3150 is a phase 3 stage product being developed by Daiichi Sankyo for Hypertension With Moderate Renal Impairment. The current trial status is completed. This product is registered under clinical trial identifier NCT02807987. Target conditions include Hypertension With Moderate Renal Impairment.
What happened to similar drugs?
20 of 20 similar drugs in Hypertension With Moderate Renal Impairment were approved
Approved (20) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02885662 | Pre-clinical | Completed |
| NCT02807974 | Phase 3 | Completed |
| NCT02808026 | Phase 3 | Completed |
| NCT02807987 | Phase 3 | Completed |
| NCT02722265 | Phase 3 | Completed |
| NCT02448628 | Phase 2 | Completed |
Competing Products
20 competing products in Hypertension With Moderate Renal Impairment